Navigation Links
Key to virulence protein entry into host cells discovered
Date:8/4/2008

Blacksburg, Va. Researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have identified the region of a large family of virulence proteins in oomycete plant pathogens that enables the proteins to enter the cells of their hosts. The protein region contains the amino acid sequence motifs RXLR and dEER and has the ability to carry the virulence proteins across the membrane surrounding plant cells without any additional machinery from the pathogen. Once inside the plant cell, the proteins suppress the immune system of the plant allowing the infection to progress. The work, which focused on the virulence protein Avr1b from the soybean plant pathogen Phytophthora sojae, is published in the advance online edition of The Plant Cell.*

Oomycetes are fungal-like organisms related to marine algae that cause tens of billions of dollars of losses to agriculture, forestry and natural ecosystems every year. The oomycete Phytophthora infestans caused the Irish potato famine in the nineteenth century. Another Phytophthora species, P. ramorum, is causing Sudden Oak Death disease in California's coastal forests. P. sojae results in $200-300 million in annual losses for commercial soybean farmers in the United States and estimated annual soybean losses of $1-2 billion worldwide. All of these oomycete species contain hundreds of genes that encode for virulence proteins that have the RXLR-dEER region.**

The virulence proteins, including Avr1b, enter the soybean host where they are capable of suppressing an important process in plant immunity called programmed cell death.*** Programmed cell death is an in-built suicide mechanism that kills infected plant tissue, filling it with toxins so the pathogen can no longer feed on it. By preventing this protective mechanism in the host, the virulence proteins ensure that the pathogen can establish an unassailable foothold in the plant tissue from which the pathogen can pursue its de
'/>"/>

Contact: Barry Whyte
whyte@vbi.vt.edu
540-231-1767
Virginia Tech
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Huge virulence gene superfamily responsible for devastating plant diseases
2. Who found some new mechanisms of HBV virulence?
3. Novel approach strips staph of virulence
4. Key Anthrax Virulence Factor Discovered
5. Key to MRSA Virulence in Community Discovered
6. DIA/AAPS Co-Sponsored Conference to Examine the Immunogenicity of Therapeutic Proteins
7. Protein made by fat cells may increase risk of heart attack in older adults
8. Scientists ID Jekyll-Hyde Protein in Lou Gehrigs Disease
9. A High-Density Lipoprotein Raising Drug That Has a Lower Discontinuation Rate Than That of Extended Release Niaspan Would Earn a 20 Percent Patient Share in the Dyslipidemia Drug Market
10. Protein Gives Doctors New Tool to Detect Melanoma
11. Protein Thought to Promote Cancer Does Opposite

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ire/ -- A majority of Americans support a "public ... lack confidence that the cost, quality, value or ...next year, according to a survey released today by...spondents said they believe a public option should...n. Only about one in five, however, believes the c...
(Date:12/2/2009)... -- Reportlinker.com announces that a new market r..., Renal Disease Treatments: Products and Therapie...al-Disease-Treatments-Products-and-Therapies.html ...nd services, providing data for 2008 and estimates...ound annual growth rates (CAGRs) from 2009 to 2014...
(Date:12/2/2009)...Newswire-FirstCall/ -- The City of Seoul, the Com...e and Qualcomm Incorporated (Nasdaq: QCOM ), thro...nced the expansion of a project that provides mobi..."Seoul Family Helper" program. This project suppl...senior citizens in order to provide healthcare rel...
(Date:12/2/2009)...ounter recent increases in longevity , ,... health of the U.S. population has improved over t... quit smoking in droves, but a new study suggests ...obesity rates among Americans don,t level off or d...esity continue unchanged, the average life expecta...
(Date:12/2/2009)...-USNewswire/ -- Huntington Memorial Hospital,s str... from the Joint Commission, designating the hospit... will join the network of "approved stroke center"..."This is a significant milestone for the hospital,...ena and its surrounding communities," said Arbi Oh...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Survey: Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 3Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 5Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 6Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 7Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 8Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 9Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 10Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 2Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 4Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2
...ing Inc. (NYSE: BKD ) today announced that Mark...er, will make a presentation regarding the Company...Francisco, California on Tuesday, May 19, 2009, be...ebcast/jmp8/bkd/ as well as through the Investo...
...cational initiatives between the clinical staff at...their Partners program suggest that educational in... quality of care for cancer patients at community ...ymph nodes that were surgically removed in colorec...
...reast cancer patients , , THURSDAY, May 14...he nausea-easing powers of ginger that many grandm...the spice helped cancer patients who were undergoi...motherapy, and reduced nausea will lead to improve...
...c. (NYSE: HGR ) will replace Gevity HR Inc. (NAS...se of trading on a date to be announced. Gevity HR... Inc. in a transaction expected to close soon. , ...edic Group Inc. owns and operates orthotic and pro...
...ess, bus tour will be stopping in Utah throughout ...er to help uninsured and financially-struggling Ut...prescription medicines for free or nearly free. Wi...is raising awareness of patient assistance program...
...pproval of Prevacid OTC(R) 24HR, The Procter &... , (Photo: http://www.newscom.com/cgi-bin/prn...ctor and pharmacist recommended over-the-counter h...rket and since 2003, millions of consumers have ma...
Other Medicine News:Health News:Educational initiatives improve quality of care delivery 2Health News:Ginger Eases Nausea From Chemo 2Health News:Standard & Poor's Announces Changes to U.S. Index 2Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 4Health News:P&G Response to FDA Approval of Prevacid OTC(R) 24HR 2
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Cardiovascular Devices: Technologies an...com/p0166823/Cardiovascular-Devices-Technologies-a...e view of the cardiovascular devices industry on a...major types of cardiovascular diagnostic equipment...
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Hemoglobin A1c Monitoring - Global Marke...230/Hemoglobin-A1c-Monitoring---Global-Market-Tren...he need for effective therapy to manage diabetes h...r monitoring the treatment efficiency of the disea...
(Date:12/2/2009)...Newswire-USNewswire/ -- Jupiter Medical Center h...c tools available into its imaging program, the ne...e system delivers highly detailed images of the hu...nd unique applications, including dual breast scan...s with renal dysfunction. This results in shorter...
Breaking Medicine Technology:Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 2Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 3Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 4Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 5Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 6Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 7Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 8Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 9Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 10Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 11Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 12Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 2Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 3Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 4Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 5Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 6Reportlinker Adds Hemoglobin A1c Monitoring - Global Market Trends 7Jupiter Medical Center Announces New High-Definition MRI System 2PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June 12569 1PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June 12569 2Tribe Makes Payment of 24945 000 to Assist County With Emergency Services and Fire Protection 48489 1Tribe Makes Payment of 24945 000 to Assist County With Emergency Services and Fire Protection 48489 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 1Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 3
...tion leadership and long-term commitment to hepati...chering-Plough Corporation (NYSE: SGP ) today pr...nvestigational oral hepatitis C protease inhibitor...believes boceprevir has the potential to be a firs...r treating chronic hepatitis C. The company also ...
...chering-Plough Corporation (NYSE: SGP ) today re...denosine2a receptor antagonist, met the primary en...s suffering from moderate to severe Parkinson,s di... involuntary movements (dyskinesias). The trial r...R&D Update meeting being hosted for analysts a...
Other Medicine Technology:Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 2Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 3Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 4
Urocare® Vinyl Urinary Leg Bags - Medium with Twist Drain
Urocare® Vinyl Urinary Leg Bags - Large with Twist Drain
Urocare® Latex Urinary Leg Bag - Short-Wide
Urocare® Latex Urinary Leg Bag - Large
Medicine Products: